Prevalence and clinical manifestations of polycystic ovarian syndrome among adolescent and adult women in Davangere, Karnataka
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20261261Keywords:
PCOS, Adolescence, Acne, Hirsutism, Overweight, ObeseAbstract
Background: The prevalence of a disease in a particular region is always a necessary tool for any control measures. There are no full-fledged published data on PCOS prevalence and clinical manifestation patterns in our study setting geographic location. This study aimed to study the prevalence and clinical manifestation of PCOS among adolescents and adult women.
Methods: This is a prospective cross-sectional observational study conducted with total of 426 participants. A structured questionnaire was given to all the participants and collected data was assessed. Questionnaire included the following components; (i) Knowledge assessment, (ii) Anthropometric assessment, (iii) Clinical history, and (iv) Menstrual history included irregularity as well as presence of oligomenorrhea after one year of menarche, wait gain and hirsutism/ androgen production assessment (skin problems, and hair distribution).
Results: 27% of adolescent PCOS cases were found to be in the age group of 10-18 years. While, 11% of adult women with PCOS were found to be in the age group of 19-45 years. Majority of the study participants with PCOS were found to be obese (49.1%) followed be overweight (31.7%), and non-obese (19.2%) indicating an association of BMI with PCOS. Majority of the PCOS cases i.e., 37.3% were presented with acne/oily skin followed by alopecia (17.4%), mood swings/depression (16.8%), pigmentation (16.1%), and hirsutism (12.4%).
Conclusions: PCOS is increasingly encountered during adolescence with clinical manifestation of acne/oily skin in our study setting. Furthermore, PCOS was associated with overweight and obesity. Therefore, our study is indicative of the fact that all overweight and/or obese adolescence with acnes and/or oily skin should be screened for PCOS for early diagnosis and management.
References
Franks S. Polycystic ovary syndrome in adolescents. Int J Obes (Lond). 2008;32(7):1035-41.
Azziz R, Dumesic DA, Goodarzi MO. Polycystic ovary syndrome: An ancient disorder? Fertil Steril. 2011;95(5):1544-8.
Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, Nikfar S, Tsatsakis A, Abdollahi M. Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. Int J Mol Sci. 2022;23(2):583.
Laddad MM, Kshirsagar NS, Shinde GP, Shivade VS. Study of prevalence and determinants of polycystic ovarian syndrome among adolescent girls in rural area: a prospective study. Int J Reprod Contracept Obstet Gynecol. 2019;8(8):3135-9.
Khan MJ, Ullah A, Basit S. Genetic basis of polycystic ovary syndrome (PCOS): current perspectives. Appl Clin Genet. 2019;12:249-60.
Desai NA, Tiwari RY, Patel SS. Prevalence of polycystic ovary syndrome and its associated risk factors among adolescent and young girls in Ahmedabad region. Ind J Pharm Pract.2018;11(3):119-25.
Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adol Gynecol. 2011;24(4):223-7.
Witchel SF, Oberfield SE, Pena AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls [presentation]. J Endocr Soc. 2019;3(8):1545-73.
Saadia Z. Follicle stimulating hormone (LH: FSH) ratio in polycystic ovary syndrome (PCOS)-obese vs. non-obese women. Med Arch. 2020;74(4):289-93.
Christ JP, Cedars MI. Current Guidelines for Diagnosing PCOS. Diagnostics (Basel). 2023;13(6):1113.
Divya K, Mounisha B, Sowmya RV. Prevalence of polycystic ovarian syndrome among young women who attended tertiary care hospital, Visakhapatnam. Int J Curr Pharm Res. 2024;16 (4):75-8.
Lyon CC. Acne: Diagnosis and Management. JR Soc Med. 2001;94(12):652.
Sutaria AH, Masood S, Saleh HM, Schlessinger J. Acne Vulgaris. 2023. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.
Zouboulis CC. Acne as a chronic systemic disease. Clin Dermatol. 2014;32(3):389-96.
Ozdemir S, Ozdemir M, Gorkemli H, Kiyici A, Bodur S. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism. Acta Obstet Gynecol Scand. 2010;89(2):199-204.
Alan S, Cenesizoglu E. Effects of hyperandrogenism and high body mass index on acne severity in women. Saudi Med J. 2014;35(8):886-9.
Kansra AR. Polycystic ovary syndrome in adolescents. J Clin Out Manag. 2016;23(5):xx.
Kamboj MK, Bonny AE. Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies. Translational Pediatr. 2017;6(4):248.
Singh A, Vijaya K, Laxmi KS. Prevalence of polycystic ovarian syndrome among adolescent girls: a prospective study. Int J Reprod Contracept Obstet Gynecol. 2018;7(11):4375-8.
Ganie MA, Rashid A, Sahu D, Nisar S, Wani IA, Khan J. Prevalence of polycystic ovary syndrome (PCOS) among reproductive age women from Kashmir valley: a cross-sectional study. Int J Gynaecol Obstet. 2020;149(2):231-6.
Deswal R, Nanda S, Ghalaut VS, Roy PS, Dang AS. Cross-sectional study of the prevalence of polycystic ovary syndrome in rural and urban populations. Int J Gynaecol Obstet. 2019;146(3):370-9.
Joseph N, Reddy AG, Joy D, Patel V, Santhosh P, Das S, Reddy SK. Study on the proportion and determinants of polycystic ovarian syndrome among health sciences students in South India. J Nat Sci Biol Med. 2016;7(2):166-72.
Joshi B, Mukherjee S, Patil A, Purandare A, Chauhan S, Vaidya R. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Ind J Endocrinol Metabol. 2014;18(3):317.
Batista, FAS, Paula A. Types of Acne and associated therapy. Am Research J. 2006; 15:257-66.
Emiroğlu N, Cengiz FP, Kemeriz F. Insulin resistance in severe acne vulgaris. Postepy Dermatol Alergol. 2015;32(4):281-5.
Chandra M, Garg P, Vats K, Tibrewal A. An observational study on prevalence and determinants of PCOS in women presenting with acne vulgaris to a tertiary care hospital in North India. Int J Community Med Public Health. 2021;8:1270-5.
Raja SA, Prasad PVS, Kaviarasan PK. Prevalence and pattern of PCOS in women presenting with acne, a hospital based prospective observational study. Int J Res Med Sci. 2018;6(3):899-903.
Zandi S, Farajzadeh S, Safari H. Prevalence of polycystic ovary syndrome in women with acne: hormone profiles and clinical findings. J Am Acad Dermatol. 2016;20(4):194-8.
Kelekci KH, Kelekci S, Incki K, Ozdemir O, Yilmaz B. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne. Int J Dermatol. 2010;49(7):775-9.
Abdullah Z, Masood Q, Hassan I, Kirmani O. Hormonal profile and polycystic ovaries in women with acne vulgaris. Ind J Dermatol Venereol Leprol. 2013;79(3):422-4.
Maluki AH. The frequency of polycystic ovary syndrome in females with resistant acne vulgaris. J Cosmet Dermatol. 2010;9(2):142-8.
Betti R, Bencini PL, Lodi A, Urbani CE, Chiarelli G, Crosti C. Incidence of polycystic ovaries in patients with late-onset or persistent acne: hormonal reports. Dermatologica. 1990;181(2):109-11.
Tehrani M, Parvizi M, Moghadam AS, Heshmat R, Khas SNZ, Golchin M. The prevalence of polycystic ovary syndrome in Iranian women with gestational diabetes: a pilot study. Iranian J Diab Lipid Disorders. 2009:57-64.
Falsetti L, Gambera A, Andrico S, Sartori E. Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences. Gynecol Endocrinol. 2002;16(4):275-84.
Lee AT, Zane LT. Dermatologic manifestations of polycystic ovary syndrome. Am J Clin Dermatol. 2007;8(4):201-19.
Yu NE, Ho PC. Polycystic ovary syndrome in Asian women. Semin Reprod Med. 2008;26(1):14-21.